Evaluation of serum CCL18 as a potential biomarker for ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of serum CCL18 as a potential biomarker for ovarian cancer

Published:2017-12-12 Issue:1 Volume:21 Page:97-104
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Yuan Linjing¹¹,Wan Jianxin²¹,Huang Chumei²,Liang Jingjing³,Liu Min²,Yue Caifeng²,Li Laisheng²

Affiliation:

1. Department of Gynaecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong, China

2. Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong, China

3. Department of Emergency, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference28 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

3. Genetic and molecular changes in ovarian cancer;Hollis;Cancer Biol Med,2016

4. Current clinical application of serum biomarkers to detect ovarian cancer;Nowak;Prz Menopauzalny,2015

5. HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma;Midulla;Tumour Biol,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma;Experimental Eye Research;2023-05

2. CCL18 Knockdown Suppresses Cell Growth and Migration in Thyroid Cancer;Journal of Healthcare Engineering;2022-01-25

3. The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment;Cytokine & Growth Factor Reviews;2021-08

4. CCL18 in the Progression of Cancer;International Journal of Molecular Sciences;2020-10-26

5. Killing the “BAD”: Challenges for immunotherapy in pancreatic cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3